Function and regulation of Dyrk1A: towards understanding Down syndrome
- PMID: 19685005
- PMCID: PMC11115655
- DOI: 10.1007/s00018-009-0123-2
Function and regulation of Dyrk1A: towards understanding Down syndrome
Abstract
Down syndrome (DS) is associated with a variety of symptoms, such as incapacitating mental retardation and neurodegeneration (i.e., Alzheimer's disease), that prevent patients from leading fully independent lives. These phenotypes are a direct consequence of the overexpression of chromosome 21 genes, which are present in duplicate due to non-disjunction of chromosome 21. Accumulating data suggest that the chromosome 21 gene product, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A (Dyrk1A), participates in the pathogenic mechanisms underlying the mental and other physical symptoms of DS. In this review, we summarize the evidence supporting a role for Dyrk1A in DS, especially DS pathogenesis. Recently, several natural and synthetic compounds have been identified as Dyrk1A inhibitors. Understanding the function and regulation of Dyrk1A may lead to the development of novel therapeutic agents aimed at treating DS.
Figures


Similar articles
-
Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease.J Neurochem. 2008 Mar;104(5):1333-44. doi: 10.1111/j.1471-4159.2007.05075.x. Epub 2007 Nov 14. J Neurochem. 2008. PMID: 18005339
-
DYRK1A-dosage imbalance perturbs NRSF/REST levels, deregulating pluripotency and embryonic stem cell fate in Down syndrome.Am J Hum Genet. 2008 Sep;83(3):388-400. doi: 10.1016/j.ajhg.2008.08.012. Epub 2008 Sep 4. Am J Hum Genet. 2008. PMID: 18771760 Free PMC article.
-
[Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].Yakugaku Zasshi. 2017;137(7):801-805. doi: 10.1248/yakushi.16-00236-2. Yakugaku Zasshi. 2017. PMID: 28674290 Review. Japanese.
-
Overexpression of DYRK1A inhibits choline acetyltransferase induction by oleic acid in cellular models of Down syndrome.Exp Neurol. 2013 Jan;239:229-34. doi: 10.1016/j.expneurol.2012.10.016. Epub 2012 Nov 1. Exp Neurol. 2013. PMID: 23124096
-
The role of DYRK1A in neurodegenerative diseases.FEBS J. 2011 Jan;278(2):236-45. doi: 10.1111/j.1742-4658.2010.07955.x. Epub 2010 Dec 13. FEBS J. 2011. PMID: 21156028 Free PMC article. Review.
Cited by
-
DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome.Front Behav Neurosci. 2016 Jun 3;10:104. doi: 10.3389/fnbeh.2016.00104. eCollection 2016. Front Behav Neurosci. 2016. PMID: 27375444 Free PMC article. Review.
-
Association of genetic variants with autism spectrum disorder in Japanese children revealed by targeted sequencing.Front Genet. 2024 Aug 30;15:1352480. doi: 10.3389/fgene.2024.1352480. eCollection 2024. Front Genet. 2024. PMID: 39280100 Free PMC article.
-
Protein Kinases in Obesity, and the Kinase-Targeted Therapy.Adv Exp Med Biol. 2024;1460:199-229. doi: 10.1007/978-3-031-63657-8_7. Adv Exp Med Biol. 2024. PMID: 39287853 Review.
-
Abnormalities of DYRK1A-Cytoskeleton Complexes in the Blood Cells as Potential Biomarkers of Alzheimer's Disease.J Alzheimers Dis. 2019;72(4):1059-1075. doi: 10.3233/JAD-190475. J Alzheimers Dis. 2019. PMID: 31683476 Free PMC article.
-
Insights from the protein interaction Universe of the multifunctional "Goldilocks" kinase DYRK1A.Front Cell Dev Biol. 2023 Oct 12;11:1277537. doi: 10.3389/fcell.2023.1277537. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37900285 Free PMC article. Review.
References
-
- Lejeune J, Gautier M, Turpin R. Study of somatic chromosomes from 9 mongoloid children. C R Hebd Seances Acad Sci. 1959;248:1721–1722. - PubMed
-
- Korenberg JR, Chen X-N, Schipper R, Sun Z, Gonsky R, Gerwehr S, Carpenter N, Daumer C, Dignan P, Disteche C, Graham JM, Jr, Hugdins L, McGillivray B, Miyazaki K, Ogasawara N, Park JP, Pagon R, Pueschel S, Sack G, Say B, Schuffenhauer S, Soukup S, Yamanaka T. Down syndrome phenotypes: the consequences of chromosomal imbalance. Proc Natl Acad Sci USA. 1994;91:4997–5001. doi: 10.1073/pnas.91.11.4997. - DOI - PMC - PubMed
-
- Gardiner K (2007) Overview of the genes of the human chromosome 21. In: Pritchard M, Reeves RH, Dierssenc M, Patterson D, Gardiner KJ (eds) Down syndrome and the genes of human chromosome 21: current knowledge and future potentials. Report on the expert workshop on the biology of chromosome 21 genes: towards gene-phenotype correlations in Down syndrome. September 28-October 1, 2007, Washington D.C. - PubMed
-
- Korenberg JR, Kawashima H, Pulst S-M, Ikeuchi T, Ogasawara N, Yamamoto K, Schonberg SA, West R, Allen L, Magenis E, Ikawa K, Taniguchi N, Epstein CJ. Molecular definition of a region of chromosome 21 that causes features of the Down syndrome phenotype. Am J Hum Genet. 1990;47:236–246. - PMC - PubMed
-
- McCormick MK, Schinzel A, Petersen MB, Stetten G, Driscoll DJ, Cantu ES, Tranebjaerg L, Mikkelsen M, Watkins PC, Antonarakis SE. Molecular genetic approach to the characterization of the “Down syndrome region” of chromosome 21. Genomics. 1989;5:325–331. doi: 10.1016/0888-7543(89)90065-7. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical